Congratulations to our graduating class of 2021-2022! 🤩💊 Thank you for making my first year back @RushPharm a great one and for the honor of Preceptor of the Year! I’m so proud of all of you! 🤗 Special shout out to my mentee for presenting me with the award! 💜
The Ukrainian people need our help. If you’re looking for a way to make a difference, here are some organizations doing important work.
https://t.co/J0kn9emrIH
Super excited about our study comparing high- and low dose 4F-PCC for DOAC reversal! Special shout out to @___nonsequitur@EDPharmHand
https://t.co/IgipDkC18f
@ASHP_EMPharm @accpemedprn@ACCP
Hello #TwitterRx!
This is the official Twitter for @RushMedical's Dept of Pharmacy and Residency Programs.
We are excited to promote our virtual open house scheduled for tomorrow, Nov 17 @ 4pm CST. See below to sign up and learn about one of our great residency programs!
Come join us at the @ACCP Pharmacy Residency Showcase‼️
I will be discussing our PGY2 in Emergency Medicine.
See below for date and times for all programs.
Visit here for more info about all programs: https://t.co/ZarzSyWB27
#PharmRes#TwitteRx
SGLT2 inhibitors associated with a ⬇️ risk of major adverse CV events; The largest benefit was for an associated reduction in risk for HHF.
SGLT2 Inhibitors: CV and Kidney Outcomes in Patients with Diabetes https://t.co/76Lnr7LOzw via @JAMACardio part of @JAMANetwork
What is the effect of #SGLT2 inhibition on fatal and nonfatal #heartfailure events and renal outcomes in all randomly assigned patients with #HFrEF and in relevant subgroups from DAPA-HF and EMPEROR-Reduced trials? Find out here: https://t.co/V6tUaYXmoX
This is great! Treating heart failure is a multidisciplinary approach and we can all work together to improve GDMT optimization. #GDMTworks#riseaboveHF
@JJheart_doc @DevinMehta This is great! Treating heart failure is a multidisciplinary approach and we can all work together to improve GDMT optimization. #GDMTworks#riseaboveHF